Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vineeta Shobha
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic and Safety Outcomes From the 24-Month Phase 3 ORAL Scan Study
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Recurrent and Treatment-Resistant Pyoderma Gangrenosum, Secondary to Hidden Underlying Breast Cancer
Internet Journal of Rheumatology and Clinical Immunology
Related publications
Efficacy of Tofacitinib Monotherapy in Methotrexate-Naive Patients With Early or Established Rheumatoid Arthritis
RMD Open
Rheumatology
Allergy
Immunology
Patient-Reported Outcomes for Tofacitinib With and Without Methotrexate, or Adalimumab With Methotrexate, in Rheumatoid Arthritis: A Phase IIIB/IV Trial
RMD Open
Rheumatology
Allergy
Immunology
Efficacy and Safety of Tofacitinib in Japanese Patients With Rheumatoid Arthritis by Background Methotrexate Dose: A Post-Hoc Analysis of Clinical Trial Data
Modern Rheumatology
Medicine
Rheumatology
Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study
Modern Rheumatology
Medicine
Rheumatology
SAT0172 Long-Term Efficacy With 5-Year-Radiographic Results and Safety of Sarilumab in Combination With Csdmards in Patients With Rheumatoid Arthritis
Safety of Low Dose Methotrexate in Elderly Patients With Rheumatoid Arthritis
Postgraduate Medical Journal
Medicine
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients With Rheumatoid Arthritis Receiving Background Methotrexate: A 5-Year Extended Phase IIB Study
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Improvements in Clinical Response Between 12 and 24 Weeks in Patients With Rheumatoid Arthritis on Etanercept Therapy With or Without Methotrexate
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics